See the 2,456 pharmacies on the National E-Pharmacy Platform
Adherence for Pediatrics: Plenary
1. PEDIATRIC PLENARY: Special Issues in Adherence for Children and Adolescents Ruby FayorseyPediatric Clinical AdvisorICAP-NY Supporting Sustainable Adherence to HIV Prevention, Care & Treatment ICAP Technical Workshop October 19-22, 2009Kigali, Rwanda
2. Outline Review ICAP adherence data for children Review the pediatric adherence literature, compare LRS and HRS Developmental approach to adherence to care and treatment in pediatrics Country Examples S2S Kenya Ethiopia
3. Cumulative Pediatric ART Enrollment, as of June 2009, N=30,859 n=3,460 n=3,217 n=3,604 n=5,600 n=2,570 n=874 n=4,047 n=1,590 n=4,161 n=30,859 n=1,651 n=85 % pediatric patients on ART
4. Status of Pediatric ART Patients at ICAP HIV Care and Treatment Programs (June 2009 n=23,267*) *Excludes Cote d’Ivoire, Swaziland and Zambia due to incomplete data on status variables. ** Includes patients who transferred out while on ART.
5. Proportion of Pediatric Patients (5-15 yrs) with CD4 Count at Baseline, 6, and 12 months after ART Initiation (June 2009 PLD)
6. Cumulative Pediatric HIV Care Enrollment, as of June 2009, N =69,575 n=152 n=4,688 n=6,790 n=9,654 n=3,404 n=1,478 n=3,786 n=16,355 n=5,830 n=10,411 n=69,575 n=7,027 % pediatric patients in HIV care
7. Adolescent Enrolled in Care: The Tip of the Iceberg? (PLD June 2009 ) Total # of active children < 19 years in PLD on ART= 4428 Total/% 0-5 yrs= 2302 (52%) Total/% 6-10yrs=1179 (26%) Total/% 11-19 yrs=947 (22%) Includes data from Rwanda, Kenya, Tz and Mz, n=98 sites
8. SOCs and Pediatric Adherence Provides more detailed assessment of adherence Adherence to care and treatment % of children reporting taking > 90% of medication % of children with documented contact with HCW within 2 weeks of missed appointment % of children with CD4 done every six months Root case analysis
9. Significant Decrease in LTFU at the 13 ICAP Sites with SOCs Implementation, Sep 07 - Sep 08 P=0.003 Tene et al. Implementers Meeting 2009
10. In Summary what does the ICAP Data tell us about Adherence in Children? Programmatic data not individual data Adherence to care not treatment Clinic attendance, lost to F/U, death and stopped ART Indirect measures of adherence (CD4 change over time) Increasing population of perinatally infected adolescents Importance of SOCs to complement routinely collected data
11. What do we know about Pediatric Adherence Non-adherence is prevalent (20-50%), increases with age (Watson, 2000, Gibb 2003, Mellins 2004, Williams 2006, Martin 2007) Range of factors that influence adherence (Reddington 2000, Pontalli 2001, Steele 2003, Williams 2006, Mellins 2006, Barack 2007) Child Caregiver/family Medication Related Factors Healthcare system (Provider-patient/family relationships) Structural/Community
12. Comparing Adherence in HRS and LRS (1) Vreeman RC et al Ped Infect Dis J 2008, Simoni J M et al, Pediatrics , 2007
13. Comparing Adherence in HRS and LRS (2) Vreeman RC et al Ped Infect Dis J 2008, Simoni JM et al, Pediatrics 2007
14. Comparing Adherence in HRS and LRS (3) Vreeman RC, et al., Peds Infect Dis J 2008, Simoni JM, et al., Pediatrics 2007
15. Comparing Adherence in HRS and LRS (4) Vreeman RC et al Peds Infect Dis J 2008, Simoni JM et al, Pediatrics 2007
16. Barriers Reported by Adolescents VAS to assess adherence in adolescents in Uganda: 49% reported missing a dose in the past 30 days Age 12-18 Barriers cited were: Forgetting 39% Staying away from home 30% Sleeping through dose time 22.5% Side effect of medication 10% Focus group sessions with adolescents in Western Kenya Age10-16 Barriers to adherence Just forgetting Delaying dose because of school or work Tired of taking medications Not having food Travelling to the clinic to get meds Needing to hide the meds from others in the house hold, neighborhood and school Bakeera-Kitaka S et al. IAS 2009 Vreeman R et al. IAS 2009
17. What About Disclosure and Adherence? Inconsistent relationship between disclosure and adherence in HRS, most studies are confounded by age Studies in LRS seem to suggest improved adherence with disclosure of HIV status In Kenya, N=37(Akolo , IAS 2009) < 12 years not disclosed to (90-100% adherence) Early disclosure with ongoing support from parents/guardians (90-100% adherence) Late disclosure with ongoing support from family (80-89% adherence) In Uganda, N=42 Complete disclosure and strong parental relationships were related to good adherence (Bikaako-Kajura 2006) Study from Mulago, N=170 Disclosure of HIV diagnosis to only caregiver associated with low adherence (Nabueera-Barungi 2007)
30. Adherence Assessment Caregiver/Self-report is the least expensive and most frequently used (tends to over estimate) Concerns about social desirability and recall bias Child report accurate when developmentally appropriate Non judgmental attitude: trust, partnership and honesty MDT approach- its everyone's responsibility
31. Strategies Evaluated in the Literature to Improve Adherence in Children Few strategies for improving adherence in children have been reported in the literature Directly Observed Therapy- Gigliotti 2001, Roberts 2004 Educational Program using treatment buddies- Lyon 2003 Insertion of G tube- Shingadia 2000 Behavioral Change-Rogers 2001 Home based care/Nursing- Ellis 2006, Berrien 2004 Most are descriptive with small sample sizes Recently more data from LRS Psychosocial and treatment literacy activities- Van Winghem 2008 Family based interventions –Alicea IAS 2009 Community partnerships- Owiso IAS 2009
32. Strategies and Interventions to Facilitate Adherence (1) Child/Caregiver and Family Intensive education before starting therapy, provision of educational materials (visual and written ) Use of reminders, link to daily activities Share responsibility for remembering medication within household Small incentives for children when they take their medicines Psychosocial support services (family support/family based interventions, treatment buddies, individualized and family counseling Adherence aides (pill boxes, adherence calendar, alarms) Developmentally appropriate HIV disease education and disclosure DOT Social support/community linkages
33. Strategies and Interventions to Facilitate Adherence (2) Health care system Establish long term relationship with child, family and clinic staff Child friendly clinics Family centered care Functioning appointment systems Efficient patient defaulter tracing mechanisms Clearly defined ways to assess, monitor and provide adherence support Support groups (children, adolescents and caregivers) Mentoring of providers and counselors MDT approach to adherence Use data for quality improvement
34. Strategies and Interventions to Facilitate Adherence (3) Medication Reduce number of pills (FDC) and frequency of administration Switching large volumes to pills Labeling syringes, color coding medications Blister packs Adapt treatment to child and families lifestyle Use the most tolerable combinations Minimize side effects & drug interactions
35. Summary Adherence in children in LRS is equal or may be better than children in HRS Adherence estimates vary depending on measurement strategy self/caregiver report is most commonly used Factors affecting adherence in children and adolescents are complex and change over time Need to have the appropriate systems to facilitate adherence (appointment systems, defaulter tracing etc.) Strategies that work must be multifocal and broad, developmentally appropriate for the child, should also include caregiver, family, health system and community
37. S2S-Adherence Support for Adolescents Kenya-Pediatric Appointment and Adherence Systems Ethiopia- MDT Approach to Adherence COUNTRY EXAMPLES
38. Supporting Sustainable Adherence to HIV Prevention, Care & Treatment ICAP Technical Workshop October 19-22, 2009Kigali, Rwanda Adherence Support for Adolescents Marina Rifkin, Program Monitoring Advisor South 2 South – South Africa Partnership for Comprehensive Family HIV Care and Treatment Programs
39. Adolescents in Care at Tygerberg Children’s Hospital Currently a total of 60 (25%) of the approximately 240 children on ART are between the ages of 10 and 17 Clinical services are offered on different days for different age groups (10-11 years, 12-13 years, 14+ years) At age 18 patients are transferred to the adult clinic, based on developmental readiness 39
42. Allow for a less abrupt transition into adult care
43. Provide a holistic approach geared at adolescents, the issues they are faced with and providing tools and support structures to ensure that they are nurtured through this difficult period of their lives
55. Arts and crafts“I like the way the information was delivered. How to teach children about HIV/AIDS and the importance of giving meds as well. How to help them with their schoolwork, and I really enjoy the day and the way we were treated” - Grandma 42
60. Thanks to: 44 Sr. Vivian O’Brian Sonja Oberholse Staff of the Tygerberg Family Clinic Patients and their families
61. PEDIATRIC APPOINTMENT & ADHERENCE SYSTEMS Frida Njogu, MD, MPH ICAP Kenya Supporting Sustainable Adherence to HIV Prevention, Care & Treatment ICAP Technical Workshop October 19-22, 2009Kigali, Rwanda
62. Challenges in Pediatric Appointments, Adherence and Retention Integration of other child survival mechanisms e.g. IMCI, Immunization Change of caretaker – death of parent Elderly caretakers – literacy, ill health Dependent on ‘others’ to bring them to clinic Difficulty quantifying syrup used (compared to pill count)
63. Systems To Support Pediatric Adherence Appointment system Diary integrates appointments and assessment Integrated services Adherence support tools:
65. Integration... Dedicated peds clinic day Same day appointments for mother/caretaker and family (family care clinic concept) Integrated TB/HIV clinic for co-infected Integrated with immunization schedule On same day receive/are linked to nutrition supplementation in some sites (Machakos, UNICEF linkage) Same day have caretaker and pedpsychososcial support groups Bi-annual RBS and 3 monthly BP checks in MtitoAndei to improve retention and adherence
66. Colour Coding System Rationale: elderly caregivers Early stages of pilot SOP developed Waterproof coloured strip on syringe, corresponding coloured label on bottle Top edge on syringe marks the dose Demonstrated during dispensing, reverse demonstration at adherence assessment
68. Plans Further and more complete integration of services Roll out Color Coding system Treatment Supporter system for elderly caretakers
69. Collaboration BetweenCU-ICAP Ethiopia and The Psychosocial Unit at Adama Hospital Yoseph GutemaPediatric/PMTCT Advisor ICAP Ethiopia Kigali, RwandaOctober 21,2009 Supporting Sustainable Adherence to HIV Prevention, Care & Treatment ICAP Technical Workshop October 19-22, 2009Kigali, Rwanda
77. Cumulative no of Infants & Children Ever Started and Ever Enrolled in Care at Adama Hospital
78. UTCSA at Adama Hospital Psychologist is hired to attend to needs of children in community Provides psychological support for abused children Provides care and support for abandoned children Facilitate age determination service for children in conflict with the law
87. Next Steps Establishment of Pediatric Peer support Group/ buddies Expanding the service to other ICAP supported facilities Adama Pediatric Psychosocial unit will be model center
Source: ICAP URS, June 2009Note: Includes sites currently supported by ICAP and reporting. Note: Swaziland was unable to report Apr-June; Numbers from Jan-Mar 09 were carried over Take home message:There is large variability for proportion of <1 year enrolled in ART across countries. This is likely a reflection of the variation in the availability of early infant diagnosis. Note that the proportion of patients <1 year in ART care is about half of that in HIV care (23% v.s. 39% from previous slide).
Source: ICAP URS, March 2009Note1: Includes sites currently supported by ICAP and reporting. Take home message:Among those discontinued ART (14%), the majority (57%) had not had contact with the clinic for by at least 90 days (Lost to follow up), 39% had been reported dead and 4% stopped treatment stopped ART but continued in care.Person time:ART discontinuation per 1000 person years can capture the time element that is not captured by cumulative discontinuation rate reported each quarter. Two sites may have the same cumulative discontinuation rate at 20% but one site may have started providing ART 6 months ago while the other site may have started 2 years ago. Calculating the rate in person-time will show that the first site is losing patients at a greater rate than in the second site. Below, is a step-by-step explanation of how the rates were calculated:A. Assume patients starting ART on average started at “mid-point” of the quarter (i.e., at 1.5 months).100 patients started on ART during the quarter are assumed to have contributed 100 persons x 1.5 months or 150 person-months on ART during the quarterB. Number on ART at the beginning of the quarter is used to calculate the number of person-years of ART use that could be contributed if there were no deaths, transfers, stopping, or LTF during the quarter.500 patients enrolled as of the end of the previous quarter are assumed to contribute 500 persons x 3 months, or 1500 person-months of ART during the quarterC. Patients who stop ART during the quarterPatients who stop ART (die, transfer, are LTF, or otherwise stopped ART) are assumed to have done so at the midpoint of the quarter.35 people stop ART for any of the above reasons, they are assumed to contribute 35 persons x 1.5 months, or about 82 person-months.This person time must be subtracted from that in B in order to correct for the assumption of no stoppages during the quarter.Person-time on ART during the quarter= A + (B – C)=150+1500-82=1568 pm
Indirect measure of adherence. Under estimate of children who have received CD4. due to missing and undocumented data. data is from Jan 2005- June 2009Window periods:Baseline (1 month before and 1 month after)6 months (2 month before and 2 month after)12 months (2 month before and 2 month after)Dataset includes only the results of CD4 counts so if it’s not in the dataset we cannot know if it is missing (the test was done but not entered in the dataset) or if it was ordered but not done.This slide is a bit misleading. Probably because of undocumented or missing data? However the take home message is this. Children are not getting CD4 counts as recommended.
Source: ICAP URS, June 2009Note: Swaziland was unable to report Apr-June; Numbers from Jan-Mar 09 were carried over Take home message:Large majority of pediatric patients receiving HIV care were under 5 years of age (62%). In Nigeria and Zambia, the majority of pediatric patients were under 1. This is because of varying reporting requirements. On average kids between 0-2 should account for no more than 1/5 th and with improved and scale upof PMTCT services we should expect this number to decrease over time.
Adolescents are increasing and currently account for 1/5 of children in the PLD on ART. With time we expect this number to increase if we continue to implement strong PMTCT programs
Two systemic reviews of pediatric adherence in the literatureOne published in 2007 primarily HRSThe second published in 2008 was a review of Pediatric adherence n low and middle income countries.CaveatsVery early in scale-up experienceMostly smaller, non-representative samplesGenerally involving treatment-naïve patients
Study done in adolescents patients attending HIV clinic at Mulago Hospital. Used visual analogue scale to assess adherence. There were 76 adolescents who had been on HAART for at least 15 daysMedian age 13.7 (12-18 years)68% attending school27% lived in a HH where another parent was taking ARVsStudy form Kenya-Small numbers 23 adolescents , 3 focus group discussions with kids in 2 ART clinicsAge range 10-16 years only 2 had biological parents alive Voiced concerns about disclosing non adherence to their health care providersConcerned about secrecy in procurement, administration storage and disposal of medications
Looks at adherence to treatmentAkolo- small study only 37 participants half were disclosed to.Uganda- small study only 42 children ( 5-17 years median age 12 yearsMulago large study (170 children)- used self report, clinic based pill counts and unannounced pill counts at home.
What are the developmental characteristics that impact adherenceWhat are some of the adherence challenges you can expect in each developmental stage?How would you provide developmentally appropriate adherence education and preparation? How will you monitor and support adherence?
ARV treatment is rarely an emergencyTake time to prepare the child and the caregiver Personalize medication administration to match the specific aspects of a child’s and family’s lifeAddress the WHO, WHAT, WHEN, WHERE and HOW of medication administration
There is no perfect measure. Each method had advantages , disadvantages and trade offs.Emphasize the importance of honest reportingImportance of multidisciplinary approach to monitoringEmphasize need for communication with health care team (Trust, Partnership, Honesty)
Only one randomized study by Berrien evaluated Home nursing as a means of increasing adherence with 67 families. Designed to identify and resolve barriers to adherence. Used pill swallowing, and education. In the treatment group knowledge scores improved but self reported adherence marginally improved.